DENVER, July 26 /PRNewswire/ -- Creative Clinical Concepts, Inc., has announced that its aspirin resistance test is now available nationwide. The new test, called AspirinWorks(R), is ideally suited for patients on long-term aspirin therapy and can be ordered by any doctor's office or hospital laboratory in the U.S.
AspirinWorks (http://www.aspirinworks.com/) is a simple urine test that measures an individual's response to aspirin dosage and allows physicians to adjust the dosage or recommend alternative therapy.
"Recent national media coverage, including the New York Times, Good Morning America and NBC Nightly News, has focused a lot of attention on the critical issue of aspirin resistance," said Gordon Ens, President of Creative Clinical Concepts. "More than 20 million Americans take aspirin regularly to help prevent heart attacks and strokes; however, many aspirin users are not receiving the anti-clotting benefits of aspirin."
"We want people to know there are tests available," said Ens. "This can be vital information for patients on aspirin therapy, because we know that up to 25 percent -- and maybe more -- of patients who are taking aspirin to prevent a heart attack or stroke are resistant or taking an inadequate dosage."
Ens said if patients are found to be aspirin resistant, it may be appropriate to increase their dosage or administer a different drug. Sometimes the problem is simply that a patient is non-compliant or taking medications that interfere with aspirin.
While studies have shown that aspirin-resistant patients are three times more likely to suffer cardiovascular death than their non-aspirin resistant counterparts, more clinical studies are ongoing to verify that changing a patient's therapy will change outcomes.
"This test is simple, relatively inexpensive, and reflects the effectiveness of aspirin on platelets in the patients body," said Ens. "It's another tool in a physician's arsenal in the battle against heart disease and stroke."
A number of laboratories located throughout the country are now offering the AspirinWorks test and can perform the test for doctors' offices. Any doctor's office interested in offering the test can get a specimen collection and shipping kit sent to them immediately by calling 866-320-9333.
AspirinWorks -- a reliable alternative to blood testing methods -- is a urine test that measures the generation of thromboxane, the clot-inducing substance that aspirin is supposed to block. Instead of having to deal with the complexities and costs of drawing blood in a physician's office, doctors can simply collect a urine sample and send it to a laboratory for testing.
About AspirinWorks
AspirinWorks(R) is a division of Creative Clinical Concepts, Inc., an innovative company providing unique products that enhance patient care and management. AspirinWorks has established a network of laboratories across the U.S. that performs the test by the same method, utilizing a unique set of controls. The company's goal is to ultimately standardize aspirin therapy resistance testing in the U.S., in order to help improve patient outcomes and reduce morbidity and mortality from cardiovascular disease. President and founder of Creative Clinical Concepts, Gordon Ens, previously founded Colorado Coagulation Consultants, Inc. (CCC) a national coagulation laboratory, and served as its President and Laboratory Director until 1997 when he sold CCC to Esoterix, Inc. He served as President of Esoterix Coagulation from 1997 through 2000. Ens also serves as an independent consultant in the field of blood coagulation. For more information on AspirinWorks and the AspirinWorks Test, call 303-320-9333, toll free 866-320-9333 or visit http://www.aspirinworks.com/.
Creative Clinical Concepts, Inc.CONTACT: Media, Dan Snyders of Armada Medical Marketing,+1-303-623-1190, ext. 230, mobile, +1-720-231-9990, dan@gda-pr.com, forCreative Clinical Concepts, Inc.
Web site: http://www.aspirinworks.com/
